These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37379801)

  • 21. The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.
    Khamashta MA; Bruce IN; Gordon C; Isenberg DA; Ateka-Barrutia O; Gayed M; Donatti C; Guillermin AL; Foo J; Perna A
    Lupus; 2014 Mar; 23(3):273-83. PubMed ID: 24356612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Systemic Lupus Erythematosus Flares on Clinical and Economic Outcomes: The CHAMOMILE Claims Database Study in Germany.
    Ding B; Pignot M; Garal-Pantaler E; Villinger B; Schefzyk S; Desta B; Stirnadel-Farrant HA; Schwarting A
    Rheumatol Ther; 2024 Apr; 11(2):285-299. PubMed ID: 38252212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study.
    Huang SP; Guisinger A; Averell C; Bell CF; Rubin B
    Rheumatol Ther; 2023 Jun; 10(3):551-562. PubMed ID: 36738424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and economic characterization of mild, moderate, and severe systemic lupus erythematosus: Real-world observation across payer channels in the United States.
    Wu SS; Perry A; Tkacz J; Bryant G
    J Manag Care Spec Pharm; 2023 Sep; 29(9):1010-1020. PubMed ID: 37610115
    [No Abstract]   [Full Text] [Related]  

  • 25. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
    Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O
    Semin Arthritis Rheum; 2016 Jun; 45(6):684-90. PubMed ID: 26743074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A structured literature review of the direct costs of adult systemic lupus erythematosus in the US.
    Slawsky KA; Fernandes AW; Fusfeld L; Manzi S; Goss TF
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1224-32. PubMed ID: 21584945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world evaluation of costs of illness for pneumonia in adult patients in Dubai-A claims database study.
    Al Dallal SAM; Farghaly M; Ghorab A; Elaassar M; Haridy H; Awad N; Chickballapur Ramachandrachar B; Natarajan A
    PLoS One; 2021; 16(9):e0256856. PubMed ID: 34469441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Annual Direct Cost and Cost-Drivers of Systemic Lupus Erythematosus: A Multi-Center Cross-Sectional Study from CSTAR Registry.
    Wang H; Li M; Zou K; Wang Y; Jia Q; Wang L; Zhao J; Wu C; Wang Q; Tian X; Wang Y; Zeng X
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare costs and resource utilization in patients with severe aplastic anemia in the US.
    Cai B; Said Q; Li X; Li FY; Arcona S
    J Med Econ; 2019 Oct; 22(10):1055-1062. PubMed ID: 31296074
    [No Abstract]   [Full Text] [Related]  

  • 30. Burden of lupus activity on health care resources utilization in Buenos Aires, Argentina.
    Alvarado RN; Alle G; Tobar-Jaramillo MA; Palomino LC; Cáceres AG; Rosa JE; Machnicki G; Zazzetti F; Soriano E; Scolnik M
    Lupus; 2023 Dec; 32(14):1656-1665. PubMed ID: 37955177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus.
    Park SY; Joo YB; Shim J; Sung YK; Bae SC
    Rheumatol Int; 2015 Nov; 35(11):1809-15. PubMed ID: 26254885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims.
    Garris C; Shah M; Farrelly E
    Cost Eff Resour Alloc; 2015; 13():9. PubMed ID: 26019689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct cost of management and treatment of active systemic lupus erythematosus and its flares in Spain: the LUCIE Study.
    Cervera R; Rúa-Figueroa I; Gil-Aguado A; Sabio JM; Pallarés L; Hernández-Pastor LJ; Iglesias M
    Rev Clin Esp (Barc); 2013 Apr; 213(3):127-37. PubMed ID: 23398815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease.
    Karve S; Candrilli S; Kappelman MD; Tolleson-Rinehart S; Tennis P; Andrews E
    J Pediatr; 2012 Oct; 161(4):662-670.e2. PubMed ID: 22578787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis.
    Wu B; Deshpande G; Gu T; Popelar B; Philbin M; Wan GJ
    J Med Econ; 2017 Nov; 20(11):1170-1177. PubMed ID: 28760047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Retrospective Administrative Claims Database Evaluation of the Utilization of Belimumab in US Managed Care Settings.
    Ke X; Eisenberg Lawrence DF; Oglesby A; Patel J; Kan H; Boggs R
    Clin Ther; 2015 Dec; 37(12):2852-63. PubMed ID: 26547483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany.
    Schultze M; Garal-Pantaler E; Pignot M; Levy RA; Carnarius H; Schneider M; Gairy K
    BMC Rheumatol; 2024 May; 8(1):18. PubMed ID: 38755673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK.
    Stirnadel-Farrant HA; Golam SM; Naisbett-Groet B; Gibson D; Langham J; Langham S; Samnaliev M
    Rheumatol Ther; 2023 Oct; 10(5):1183-1197. PubMed ID: 37400683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic lupus erythematosus and associated healthcare resource consumption in selected cities from the Russian Federation, Republic of Kazakhstan and Ukraine: the ESSENCE study.
    Nasonov E; Soloviev S; Davidson JE; Lila A; Togizbayev G; Ivanova R; Baimukhamedov C; Omarbekova Z; Iaremenko O; Gnylorybov A; Shevchuk S; Vasylyev A; Makarova J; Tariq L
    J Med Econ; 2018 Oct; 21(10):1006-1015. PubMed ID: 29992845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States.
    Clarke AE; Yazdany J; Kabadi SM; Durden E; Winer I; Griffing K; Costenbader KH
    Semin Arthritis Rheum; 2020 Aug; 50(4):759-768. PubMed ID: 32531505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.